Publicaciones en colaboración con investigadores/as de University of Verona (19)

2024

  1. Validation of the Quality Analysis of Medical Artificial Intelligence (QAMAI) tool: a new tool to assess the quality of health information provided by AI platforms

    European Archives of Oto-Rhino-Laryngology, Vol. 281, Núm. 11, pp. 6123-6131

2023

  1. Correction: Lymph node metastasis in level IIb in oropharyngeal squamous cell carcinoma: a multicentric, longitudinal, retrospective analysis (European Archives of Oto-Rhino-Laryngology, (2023), 280, 2, (869-876), 10.1007/s00405-022-07647-6)

    European Archives of Oto-Rhino-Laryngology

  2. Impact of lymph node ratio and number of lymph node metastases on survival and recurrence in laryngeal squamous cell carcinoma

    Head and Neck, Vol. 45, Núm. 9, pp. 2274-2293

  3. Lymph node metastasis in level IIb in oropharyngeal squamous cell carcinoma: a multicentric, longitudinal, retrospective analysis

    European Archives of Oto-Rhino-Laryngology, Vol. 280, Núm. 2, pp. 869-876

2022

  1. Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study

    The British journal of surgery, Vol. 109, Núm. 7, pp. 617-622

  2. International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis

    JAMA Dermatology, Vol. 158, Núm. 5, pp. 561-572

2021

  1. A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study

    Journal of Medical Virology, Vol. 93, Núm. 2, pp. 983-994

  2. Erratum: Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19 (Journal of Perinatal Medicine (2020) 48:9 (950-958) DOI: 10.1515/jpm-2020-0355)

    Journal of Perinatal Medicine

  3. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations

    Journal of the European Academy of Dermatology and Venereology, Vol. 35, Núm. 2, pp. 281-317

  4. First-In-Human Phase I Study of a Next-Generation, Oral, TGFb Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer

    Clinical Cancer Research, Vol. 27, Núm. 24, pp. 6666-6676

  5. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection

    Ultrasound in Obstetrics and Gynecology, Vol. 57, Núm. 2, pp. 232-241

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

  2. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 1: treatment and monitoring recommendations

    Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 11, pp. 2461-2498

  3. Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19

    Journal of Perinatal Medicine, Vol. 48, Núm. 9, pp. 950-958

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

2016

  1. Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies

    Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344

  2. Evidence-based guidelines for the management of exocrine pancreatic insufficiency after pancreatic surgery

    Annals of Surgery, Vol. 264, Núm. 6, pp. 949-958

2015

  1. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35

2014

  1. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

    Arthritis Research and Therapy, Vol. 16, Núm. 1